In this interview, we sit down with Eeva Broberg, ECDC Principal Expert on respiratory viruses, who tells us why respiratory syncytial virus (RSV) is an often overlooked disease which represents a considerable risk to certain groups every winter.

Eeva also talks about the impact on healthcare, and whether current treatments like monoclonal antibodies and the introduction of vaccines in Europe are a game changer.

Read more about RSV on the European Vaccination Information Portal: vaccination-info.europa.eu/en/rsv